CASR and breast carcinoma: To investigate the role of the CaSR on breast cancer cells osteolytic potential, we used MDA-MB-231 cells, an estrogen-independent breast cancer cell line able to colonize bone [9] and to induce osteolytic metastasis [10, 11].